HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lu Su Selected Research

Tight Junction Proteins

10/2020Polysaccharide from spore of Ganoderma lucidum ameliorates paclitaxel-induced intestinal barrier injury: Apoptosis inhibition by reversing microtubule polymerization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Lu Su Research Topics

Disease

12Neoplasms (Cancer)
04/2024 - 09/2015
3Inflammation (Inflammations)
10/2022 - 01/2015
3Breast Neoplasms (Breast Cancer)
10/2020 - 01/2018
2Infarction (Infarctions)
02/2020 - 01/2016
1Lung Neoplasms (Lung Cancer)
04/2024
1Autoimmune Diseases (Autoimmune Disease)
03/2024
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
03/2024
1Ulcerative Colitis
03/2024
1Rheumatic Diseases (Rheumatism)
10/2023
1Bronchitis
10/2023
1Laryngopharyngeal Reflux
02/2023
1Diabetic Neuropathies (Diabetic Neuropathy)
01/2023
1Diabetes Complications
01/2023
1Rheumatoid Arthritis
01/2023
1Polyps
10/2022
1Weight Loss (Weight Reduction)
10/2022
1Fatigue
01/2022
1Urinary Tract Infections (Urinary Tract Infection)
01/2021
1Endotoxemia
10/2020
1Reperfusion Injury
02/2020
1Brain Ischemia (Cerebral Ischemia)
02/2020
1Ischemia
02/2020
1Glioma (Gliomas)
08/2018
1Dysbiosis
01/2018
1Osteosarcoma (Osteogenic Sarcoma)
01/2018
1Carcinogenesis
01/2018
1Metabolic Diseases (Metabolic Disease)
10/2017
1Insulin Resistance
10/2017
1Obesity
10/2017
1Fatty Liver
10/2017

Drug/Important Bio-Agent (IBA)

3Paclitaxel (Taxol)FDA LinkGeneric
10/2020 - 01/2018
3Proteins (Proteins, Gene)FDA Link
08/2018 - 10/2017
2Polysaccharides (Glycans)IBA
01/2019 - 01/2018
216S Ribosomal RNAIBA
01/2018 - 01/2018
1CrizotinibIBA
04/2024
1Tyrosine Kinase InhibitorsIBA
04/2024
1IronIBA
04/2024
1Interleukin-2 (IL2)IBA
03/2024
1CytokinesIBA
03/2024
1Therapeutic UsesIBA
04/2023
1Contrast MediaIBA
04/2023
1Pepsin A (Pepsin)IBA
02/2023
1Aldehyde Reductase (Aldose Reductase)IBA
01/2023
1epalrestatIBA
01/2023
1Fluorouracil (Carac)FDA LinkGeneric
10/2022
1Volatile Fatty AcidsIBA
01/2022
1CelluloseIBA
01/2022
1PrebioticsIBA
01/2022
1Hyaluronic Acid (Hyaluronan)IBA
01/2022
1Sulfates (Sulfates, Inorganic)IBA
01/2022
1XylansIBA
01/2022
1MitogensIBA
01/2021
1PolymersIBA
01/2021
1SugarsIBA
01/2021
1Cadherins (E-Cadherin)IBA
10/2020
1CateninsIBA
10/2020
1Tight Junction ProteinsIBA
10/2020
1OccludinIBA
10/2020
1Histones (Histone)IBA
02/2020
1triphenyltetrazoliumIBA
02/2020
1Histone Deacetylase InhibitorsIBA
02/2020
1Tissue Kallikreins (Tissue Kallikrein)IBA
02/2020
1salicylhydroxamic acid (SHAM)IBA
02/2020
1Protein MethyltransferasesIBA
08/2018
1AmidesIBA
08/2018
1Protons (Proton)IBA
08/2018
1APTIBA
08/2018
1MethyltransferasesIBA
08/2018
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
07/2018
1Indicators and Reagents (Reagents)IBA
01/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2018
1Glutathione (Reduced Glutathione)IBA
01/2018
1Messenger RNA (mRNA)IBA
01/2018
1Dithiothreitol (Cleland's Reagent)IBA
01/2018
1Pyruvate Dehydrogenase Acetyl-Transferring KinaseIBA
01/2018
1Reducing AgentsIBA
01/2018
1Lactate Dehydrogenase 5IBA
01/2018
1LipidsIBA
10/2017
1AdiponectinIBA
01/2015

Therapy/Procedure

2Immunotherapy
04/2024 - 09/2015
2Drug Therapy (Chemotherapy)
10/2020 - 01/2018
1Therapeutics
04/2024
1Traditional Medicine (Folk Remedies)
10/2023
1Transplantation
10/2022
1Oral Administration
10/2020
1Thrombolytic Therapy
01/2016